Table 1.

Spearman partial correlation coefficients (ρ) and 95% confidence intervals (CI) to depict associations between participant age and human periostin mRNA expression in sWAT and vWAT following adjustment for body mass index (BMI), or lipid and liver function parameters

Variable	human periostin mRNA expression in human sWAT		human periostin mRNA expression in human vWAT
	ρ (95% CI)	p‐Value	ρ (95% CI)	p‐Value
Age (n = 471)	0.10 (0.1; 0.18)	0.03	0.13 (0.04; 0.21)	0.005
Age (adj. for BMI; n = 471)	0.06 (−0.02; 0.15)	0.14*	0.09 (0.01; 0.18)	0.03
Age (adj. for body weight; n = 469)	0.06 (−0.02; 0.15)	0.17*	0.09 (0.01; 0.18)	0.04
Age (adj. for triglycerides; n = 342)	0.06 (−0.04; 0.17)	0.20*	0.09 (−0.01;0.19)	0.08*
Age (adj. for total cholesterol; n = 338)	0.07 (−0.02; 0.18)	0.15*	0.11 (0.01; 0.19)	0.03
Age (adj. for LDL cholesterol; n = 282)	0.09 (−0.02; 0.20)	0.12*	0.14 (0.03; 0.26)	0.01
Age (adj. for HDL cholesterol; n = 281)	0.07 (−0.04; 0.18)	0.24*	0.12 (0.01; 0.24)	0.03
Age (adj. for ASAT; n = 395)	0.13 (0.03; 0.23)	0.008	0.13 (0.03; 0.23)	0.007
Age (adj. for ALAT; n = 461)	0.07 (−0.02; 0.16)	0.10*	0.10 (0.01;0.19)	0.02
Age (adj. for GGT; n = 456)	0.10 (0.01; 0.19)	0.02	0.12 (0.03; 0.21)	0.008
Age (adj. for fasting glucose; n = 439)	0.12 (0.04; 0.22)	0.007	0.14 (0.05; 0.23)	0.002
Age (adj. for CRP; n = 461)	0.06 (−0.02;0.16)	0.16*	0.09 (0.01; 0.18)	0.04
Age (adj. for creatinine; n = 462)	0.10 (0.01; 0.19)	0.02	0.12 (0.04; 0.22)	0.005
Age (adj. for leukocytes; n = 466)	0.09 (0.02; 0.17)	0.05	0.12 (0.02; 0.20)	0.01

*Adjustment for biomarker leads to loss of statistical significance.